Summary
Johnson & Johnson (JNJ) reported on February 25, 2013, a preliminary assessment of the impact from Venezuela's currency devaluation on February 13, 2013. The company anticipates a charge of approximately $100 million to net income in the first quarter of 2013, translating to a negative impact of roughly $0.04 per share. This charge primarily stems from the remeasurement of its Venezuelan subsidiary's balance sheet at the new, devalued currency rate. Importantly for investors, JNJ clarified that this charge is not expected to affect the previously issued full-year 2013 earnings per share guidance, which was announced on January 22, 2013. This suggests the company has factored in potential currency fluctuations and other risks into its broader financial outlook, and the immediate impact is considered contained and not indicative of a change in strategic performance for the year.
Key Highlights
- 1JNJ expects a charge of approximately $100 million due to Venezuela's currency devaluation.
- 2The charge is estimated to negatively impact Q1 2013 EPS by approximately $0.04.
- 3The charge is a result of remeasuring the local balance sheet at the devalued currency rate.
- 4This devaluation occurred on February 13, 2013.
- 5Full-year 2013 EPS guidance remains unaffected by this charge.
- 6The company provided this update based on a preliminary assessment.